The U.S. House of Representatives yesterday passed “The Lower Drug Costs Now Act,” which would authorize Medicare to negotiate prices with drug companies.
CHA and CMA have issued a joint statement on congressional efforts to address surprise medical billing.
In August 2019, the Department of Health Care Services (DHCS) issued its final telehealth policy.
UnitedHealthcare Community Plan of California recently announced the launch of its new Medicare Advantage plan, UnitedHealthcare Dual Complete ® (HMO D-SNP), in Alameda, Fresno, Kings and Madera counties beginning January 1, 2020.
OptumRx home delivery pharmacy to require e-prescribing for controlled substances effective January 1, 2020
OptumRx, the pharmacy benefit provider for UnitedHealthcare, will require e-prescriptions for opioids and all other controlled substances for its home delivery pharmacy service effective January 1, 2020.
Medicare and other payors may provide extra payment when a procedure requires an assistant surgeon. But any time additional payment is involved, you’ve got to be sure you understand the rules and comply with them
CA launches first-of-its-kind ACEs initiative; Beginning Jan. 1, 2020, Medi-Cal will begin paying for ACEs screenings
Called the ACEs Aware initiative, it is a first-of-its-kind statewide effort for California health care providers to screen patients for Adverse Childhood Experiences (ACEs) that increase the likelihood of ACE-associated health conditions due to toxic stress.
CMA warns new surprise billing proposal would limit patient access to in-network physicians and increase costs
Statement from CMA president on the new congressional surprise billing proposals.
As the current year ends, physicians are urged verify patients' eligibility and benefits for 2020 to ensure they will be paid for services rendered.
December 31, 2019, is the last day to make changes to their Medicare participation status for 2020 as well as to finalize the transition to the new MBI number